These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 866798

  • 1. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 2. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD, Rozencweig M, Slavik M, Muggia FM.
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
    Nagel R, Kölln CP.
    Med Klin; 1976 Oct 08; 71(41):1724-8. PubMed ID: 824540
    [Abstract] [Full Text] [Related]

  • 4. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations.
    Nilsson T, JONSSON G.
    Cancer Chemother Rep; 1975 Oct 08; 59(1):229-32. PubMed ID: 1093671
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
    Catane R, Mittelman A, Kaufman J, Murphy GP.
    N Y State J Med; 1976 Nov 08; 76(12):1978-81. PubMed ID: 1069190
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
    Balogh F, Kisbenedek L.
    Int Urol Nephrol; 1975 Nov 08; 7(2):135-40. PubMed ID: 1102475
    [Abstract] [Full Text] [Related]

  • 13. [Estracyt therapy in advanced prostate cancer: current status and personal results].
    Nagel R, Leistenschneider W.
    Urologe A; 1983 May 08; 22(3):162-6. PubMed ID: 6683899
    [Abstract] [Full Text] [Related]

  • 14. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov 08; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 15. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
    Fosså SD, Fosså J, Aakvaag A.
    J Urol; 1977 Dec 08; 118(6):1013-8. PubMed ID: 926240
    [Abstract] [Full Text] [Related]

  • 16. Estramustine phosphate in the treatment of advanced prostatic cancer.
    Küss R, Khoury S, Richard F, Fourcade F, Frantz P, Capelle JP.
    Br J Urol; 1980 Feb 08; 52(1):29-33. PubMed ID: 7426949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
    Benson RC, Wear JB, Gill GM.
    J Urol; 1979 Apr 08; 121(4):452-4. PubMed ID: 439216
    [Abstract] [Full Text] [Related]

  • 19. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L, Berlin T, Boman J, Collste L, Edsmyr F, Esposti PL, Gustafsson H, Hedlund PO, Hultgren L, Leander G, Nordle O, Norlén H, Tillegård P.
    Scand J Urol Nephrol Suppl; 1980 Apr 08; 55():143-5. PubMed ID: 6259722
    [Abstract] [Full Text] [Related]

  • 20. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD, O'Donoghue EP, Kennedy CL.
    Br J Urol; 1977 Apr 08; 49(7):717-20. PubMed ID: 339986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.